These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9453624)

  • 1. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
    Retini C; Vecchiarelli A; Monari C; Bistoni F; Kozel TR
    Infect Immun; 1998 Feb; 66(2):664-9. PubMed ID: 9453624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation.
    Vecchiarelli A; Pietrella D; Lupo P; Bistoni F; McFadden DC; Casadevall A
    J Leukoc Biol; 2003 Sep; 74(3):370-8. PubMed ID: 12949240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.
    Retini C; Kozel TR; Pietrella D; Monari C; Bistoni F; Vecchiarelli A
    Infect Immun; 2001 Oct; 69(10):6064-73. PubMed ID: 11553544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.
    Monari C; Kozel TR; Bistoni F; Vecchiarelli A
    Infect Immun; 2002 Jul; 70(7):3363-70. PubMed ID: 12065474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
    van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ
    Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans.
    Retini C; Casadevall A; Pietrella D; Monari C; Palazzetti B; Vecchiarelli A
    J Immunol; 1999 Feb; 162(3):1618-23. PubMed ID: 9973421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
    da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
    Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses.
    Collins HL; Bancroft GJ
    Infect Immun; 1991 Nov; 59(11):3883-8. PubMed ID: 1937747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses.
    Mariano Andrade R; Monteiro Almeida G; Alexandre DosReis G; Alves Melo Bento C
    Cell Immunol; 2003 Apr; 222(2):116-25. PubMed ID: 12826081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells.
    Vecchiarelli A; Pietrella D; Bistoni F; Kozel TR; Casadevall A
    Immunology; 2002 Jun; 106(2):267-72. PubMed ID: 12047756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans.
    Monari C; Retini C; Palazzetti B; Bistoni F; Vecchiarelli A
    Clin Exp Immunol; 1997 Aug; 109(2):242-7. PubMed ID: 9276518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages.
    Vecchiarelli A; Pietrella D; Dottorini M; Monari C; Retini C; Todisco T; Bistoni F
    Clin Exp Immunol; 1994 Nov; 98(2):217-23. PubMed ID: 7955525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes.
    Vecchiarelli A; Monari C; Retini C; Pietrella D; Palazzetti B; Pitzurra L; Casadevall A
    Eur J Immunol; 1998 Jan; 28(1):114-21. PubMed ID: 9485191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
    J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for induction of immunosuppression during experimental cryptococcosis: role of glucuronoxylomannan.
    Chiapello L; Iribarren P; Cervi L; Rubinstein H; Masih DT
    Clin Immunol; 2001 Jul; 100(1):96-106. PubMed ID: 11414750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.
    Blackstock R
    Immunology; 2003 Feb; 108(2):158-66. PubMed ID: 12562324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.
    Sundstrom JB; Cherniak R
    Infect Immun; 1992 Oct; 60(10):4080-7. PubMed ID: 1398921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.
    Vecchiarelli A; Retini C; Casadevall A; Monari C; Pietrella D; Kozel TR
    Infect Immun; 1998 Sep; 66(9):4324-30. PubMed ID: 9712784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The still obscure attributes of cryptococcal glucuronoxylomannan.
    Rodrigues ML; Fonseca FL; Frases S; Casadevall A; Nimrichter L
    Med Mycol; 2009 Dec; 47(8):783-8. PubMed ID: 19343609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
    Yauch LE; Lam JS; Levitz SM
    PLoS Pathog; 2006 Nov; 2(11):e120. PubMed ID: 17096589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.